Bone-targeted pH-responsive cerium nanoparticles for anabolic therapy in osteoporosis
Open Access
- 1 December 2021
- journal article
- research article
- Published by KEAI Publishing in Bioactive Materials
- Vol. 6 (12) , 4697-4706
Abstract
Antiresorptive drugs are widely used for treatment of osteoporosis and cancer bone metastasis, which function mainly through an overall inhibition of osteoclast. However, not all osteoclasts are “bone eaters”; preosteoclasts (pOCs) play anabolic roles in bone formation and angiogenesis through coupling with osteoblasts and secreting platelet derived growth factor-BB (PDGF-BB). In this study, a bone-targeted pH-responsive nanomaterial was designed for selectively eliminating mature osteoclasts (mOCs) without affecting pOCs. Biocompatible cerium nano-system (CNS) was guided to the acidic extracellular microenvironment created by mOCs and gained oxidative enzymatic activity. Oxidative CNS decreased the viability of mOCs through accumulating intracellular reactive oxygen species and enhancing calcium oscillation. Non-acid secreting anabolic pOCs were thus preserved and kept producing PDGF-BB, which lead to mesenchymal stem cell osteogenesis and endothelial progenitor cell angiogenesis via PI3K-Akt activated focal adhesion kinase. In treating osteoporotic ovariectomized mice, CNS showed better protective effects compare with the current first line antiresorptive drug due to the better anabolic effects marked by higher level of bone formation and vascularization. We provided a novel anabolic therapeutic strategy in treating bone disorders with excessive bone resorption.Keywords
Funding Information
- National Natural Science Foundation of China
This publication has 42 references indexed in Scilit:
- Focal adhesion kinase and its signaling pathways in cell migration and angiogenesisAdvanced Drug Delivery Reviews, 2011
- Calcium signaling in osteoclastsBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2011
- Osteoporosis: now and the futureThe Lancet, 2011
- Novel pH-sensitive polyacetal-based block copolymers for controlled drug deliveryInternational Journal of Pharmaceutics, 2010
- Unveiling the mechanism of uptake and sub-cellular distribution of cerium oxidenanoparticlesMolecular BioSystems, 2010
- Oxidase‐Like Activity of Polymer‐Coated Cerium Oxide NanoparticlesAngewandte Chemie International Edition, 2009
- From endoplasmic-reticulum stress to the inflammatory responseNature, 2008
- NFATc1 Induces Osteoclast Fusion Via Up-Regulation of Atp6v0d2 and the Dendritic Cell-Specific Transmembrane Protein (DC-STAMP)Molecular Endocrinology, 2008
- Osteoclast differentiation and activationNature, 2003
- Epidemiology and outcomes of osteoporotic fracturesThe Lancet, 2002